Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.6% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4

2(66.7%)

N/A

1(33.3%)

3Total

Phase 4(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06676280Phase 4Recruiting

ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography

Role: lead

NCT07566091Not ApplicableNot Yet Recruiting

Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers

Role: lead

NCT05044273Recruiting

Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent

Role: lead

NCT02797548Phase 4Completed

Perioperative Antiplatelet Therapy in Patients With Drug-eluting Stent Undergoing Noncardiac Surgery

Role: lead

NCT02720419Active Not Recruiting

IRIS-Synergy Cohort in the IRIS-DES Registry

Role: lead

NCT05043948Unknown

Genome-wide Association Study of Development of Collateral Circulation for Patients With Coronary or Peripheral Artery Disease

Role: lead

NCT02981134Withdrawn

The Usefulness of Coronary CT Scan After Everolimus-eluting Bioabsorbable Scaffold Implantation for Coronary Artery Disease

Role: lead

All 7 trials loaded